Search
Showing results for "1"
News & Events
Top Up PhD ScholarshipsApplications are open for the next round of our Top Up Scholarships for students who are undertaking their research in type 1 diabetes-related fields.
News & Events
Seed Funding GrantsApplications are open for the next round of our Seed Funding Grants for researchers dedicated to type 1 diabetes
News & Events
International Clinical Trials DayTo celebrate International Clinical Trials Day, we are highlighting a couple of a current trials underway at the Children's Diabetes Centre at the Kids Research Institute Australia and Perth Children's Hospital
News & Events
Professor Davis wins Diabetes Australia awardProfessor Liz Davis, Head of Endocrinology and Diabetes at the Perth Children’s Hospital is one of three diabetes leaders to receive the Outstanding Achievement Award from Diabetes Australia.
News & Events
Wellbeing activitiesWe have put together some activities that you can do while you’re at home with your family. It’s important to talk to your family about how you are feeling, and we hope these activities will encourage those conversations while having a bit of fun.
News & Events
Medical AssessmentsPeople with type 1 diabetes require the completion of a Medical Assessment form for activities such as driving, skipper tickets and scuba-diving etc.
Research
Lessons from 50 years of curing childhood leukaemiaOne of the great success stories of modern medicine is undoubtedly the remarkable improvement in outcome for childhood cancer, achieved through the work of...
News & Events
The Kids Research Institute Australia welcomes world-leading new laws for vapesThe Kids Research Institute Australia welcomes the Federal Government's stringent vaping reforms that took effect on 1 July 2024.
Research
Start Stronger, Live Longer Resource Manual for Aboriginal Health WorkersThis resource kit for Aboriginal health workers is an exciting milestone in the Rio Tinto Aboriginal Health partnership with The Kids Research Institute Australia
Research
A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCCEsophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract with a low 5-year survival rate due to the lack of effective treatment methods. Although therapeutic monoclonal antibodies (mAbs) now play an important role in cancer therapy, effective targeted mAbs are still lacking for ESCC.